Congratulations to all VICB Members who have secured funding through the ARRA!

Below is a list of VICB NIH ARRA (American Recovery and Reinvestment Act 2009) award recipients, including PI name, title of project, institute, first year award, and special funding program, if applicable.

Source: http://report.nih.gov/recovery/arragrants.cfm

Randy Blakely, Transgenic mouse model to address heterogeneity in autism spectrum disorders. NICHD. $454,745. Research to address the heterogeneity of autism spectrum disorders.

Richard Breyer, Molecular mechanism of PGE2 receptor pressor effects. NIDDK. $23,044.

Water Chazin, Molecular biophysics training grant at Vanderbilt. NIGMS. $87,028.

Walter Chazin, S100 proteins: Structural basis of functional properties. NIGMS. $131,568.

Jeffrey Conn, Recruitment of in vivo neuropharmacologist to support CNS drug discovery research. NIMH. $703,500. Supporting new faculty recruitment to enhance research resources through biomedical research core centers.

David Cortez, Function of the ATR-ATRIP complex. NCI. $9579.

Anthony Forster, Directed evolution of inhibitors of anthrax toxin. NIAID. $159,336.

Vsevolod Gurevich, Conformational regulation of arrestin-mediated signaling. NIGMS. $279,000.

Heidi Hamm, Regulation of vascular permeability by thrombin mediated signaling pathways. NHLBI. $15,500.

Billy Hudson, Cell-matrix interactions in the glomerulus. NIDDK. $320,720.

Tina Iverson, Transition states in G-protein coupled receptor signaling. NEI. $221,170. NIH exploratory/developmental research grant program.

Carl Johnson, Circadian programs in bacteria. NIGMS. $85,525.

Jeffrey Johnston, Application of new amination reactions to natural product and nonnatural heterocycles. NIGMS. $314,161.

Ethan Lee, Biochemical reconstitution of heterotrimeric G-proteins in the WNT pathway. NIGMS. $59,134.

Daniel Liebler, Clinical proteomic technology assessment for cancer. NCI. $402,331.

Daniel Liebler, Clinical proteomic technology assessment for cancer. NCI. $395,000. Clinical proteomic technology assessment for cancer.

Andrew Link, LTQ orbitrap hybrid FT mass spectrometry system for proteomic analysis. NCRR. $499,995. Shared Instrumentation Grant Program.

Lawrence Marnett, The Vanderbilt molecular target discovery and development center. NCI & OD. $2,200,223. Research and Research Infrastructure Grand Opportunities.

John McLean, Elucidation of leukocyte and macrophage biomarker signatures from drugs of abuse. NIDA. $1,491,067. Research and Research Infrastructure Grand Opportunities.

Jennifer Pietenpol, Cancer center support grant. NCI. $46,532.

Jennifer Pietenpol, P53 signaling and cellular response after stress. $269,700.

Ned Porter, Lipid peroxidation and antioxidant mechanisms. NIEHS. $386,449.

Albert Reynolds, A mouse model for P120 downregulation in cancer. NCI. $269,630.

Sandra Rosenthal, Drug-conjugated nanocrystals for imaging and assays in neuroscience. NIBIB. $387,500. Nanoscience and Nanotechnology in Biology and Medicine.

Claus Schneider, Convergence of the COX-2 and 5-lipoxygenase pathways. NIGMS. $55,053.

Michael Stone, DNA adduct-induced mutagenesis. NCI. $251,664.

Gary Sulikowski, Chemistry-biology interface training grant. NIGMS. $87,028.